Contrive Datum Insights has published "Laboratory Information Systems Lis Market Size, Share & Industry Analysis, By Type (Standalone LIS, Integrated LIS), Delivery mode (On-premise LIS, Web-based LIS, Cloud-based LIS), Component (Services, Software), Application (Clinical Diagnostic Laboratories, Hospitals, Anatomical Pathology Laboratories, Blood Banks, Molecular Diagnostic Laboratories), Organization size (Large Laboratories and Hospital Networks, Small and Medium Laboratories), and Regional Forecast, 2026-2034". The study sizes the global laboratory information systems lis market at USD 2.75 billion in 2025 and projects growth from USD 2.99 billion in 2026 to USD 5.55 billion by 2034, a compound annual growth rate of 8.04% across the forecast period.
A laboratory information system is software, delivered either as a standalone platform or integrated into a hospital's electronic health record, that manages the receipt, tracking, testing workflow, quality control and reporting of laboratory samples and results. It is bought by clinical diagnostic laboratories, hospital and health-system laboratories, anatomical pathology laboratories, blood banks and molecular diagnostic laboratories that need to manage sample chain of custody, instrument interfacing and regulatory reporting at scale. Buyers range from large hospital-network laboratory departments to small independent and reference laboratories, each selecting a deployment mode and level of integration suited to their sample volume and IT resources.
Hospital and reference-laboratory network consolidation driving platform replacement
Hospital and reference-laboratory network consolidation driving platform replacement is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 8.04% a year, the type lines exposed to it move fastest: Integrated LIS compounds at 10.3%, taking its share of revenue from 48% to 58.02% and its value from USD 1.32 billion to USD 3.22 billion.
Where the forecast could be beaten: hospital and laboratory-network consolidation accelerates faster than the base case, pulling forward integrated and cloud-based LIS replacement across large health systems, and molecular and genomic test-volume growth exceeds the base forecast. The study puts that case at USD 6.33 billion in 2034, against USD 5.55 billion in the base.
On the downside, laboratory IT budgets tighten as reimbursement pressure squeezes hospital and independent-laboratory margins, slowing planned migrations away from legacy standalone and on-premise systems and delaying new cloud-based deployments, which would hold 2034 revenue to USD 4.77 billion. Standalone LIS, which carries 52% of 2025 revenue, already grows at only 5.49% against the market's 8.04%, so the largest part of the base is also its slowest.
Standalone LIS Scale Against Integrated LIS Momentum
Suppliers here are separated by type, not by geography. The incumbent position is Standalone LIS: 52% of 2025 revenue, USD 1.43 billion, and still 41.98% in 2034. The contested position is Integrated LIS at 10.3% growth. Few suppliers hold both, which is why a market of USD 2.75 billion supports as many participants as it does.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Delivery mode | On-premise LIS | 38.18% · USD 1.05 billion | Cloud-based LIS 13.46% |
| Component | Software | 68% · USD 1.87 billion | Services 9.81% |
| Application | Clinical Diagnostic Laboratories | 34.18% · USD 0.94 billion | Molecular Diagnostic Laboratories 13.68% |
| Organization size | Large Laboratories and Hospital Networks | 64% · USD 1.76 billion | Small and Medium Laboratories 10.19% |
- North America was the largest region in 2025, holding 41.1% of global revenue at USD 1.13 billion and reaching USD 2 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 22.9% in 2025 to 29% in 2034, with revenue growing from USD 0.63 billion to USD 1.61 billion.
- Middle East and Africa stays the smallest contributor across the period: 4.4% of revenue in 2025 and 4.3% in 2034.
- Standalone LIS was the leading type line in 2025, taking 52% of revenue at USD 1.43 billion.
- Integrated LIS is projected to grow at 10.3% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 0.99 billion in 2025, 36% of global revenue.
The study covers five axes, by type, and by delivery mode, component, application and organization size, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 4.77 billion and USD 6.33 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.